介绍

本页面提供了有关 Chris H Takimoto 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Chris H Takimoto已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:IGMS / IGM Biosciences, Inc. CHIEF MEDICAL OFFICER 154,331
US:FTSV / Forty Seven, Inc. Chief Medical Officer 0
如何解读这些图表

以下图表显示了在Chris H Takimoto进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 Chris H Takimoto 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2024-09-17 2024-09-13 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -1,487 154,331 -0.95 11.54 -17,158 1,780,795
2024-07-23 2024-07-19 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 16,250 155,818 11.64
2024-07-23 2024-07-19 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 43,750 139,568 45.66
2024-06-18 2024-06-14 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -1,570 95,818 -1.61 7.58 -11,893 725,850
2024-06-18 2024-05-15 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 3,000 97,388 3.18 5.02 15,060 488,888
2024-03-15 2024-03-14 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -2,535 94,388 -2.62 10.17 -25,782 959,973
2024-03-15 2024-03-13 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -2,889 96,923 -2.89 9.88 -28,529 957,134
2024-03-14 2024-03-12 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 46,250 99,812 86.35
2023-12-01 2023-11-29 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -1,180 53,562 -2.16 6.21 -7,331 332,781
2023-05-25 2023-05-23 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -15 54,742 -0.03 13.00 -195 711,920
2023-05-25 2023-05-23 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -1,244 54,757 -2.22 12.30 -15,302 673,538
2023-05-25 2023-05-15 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 962 56,001 1.75 11.71 11,265 655,772
2023-04-06 2023-04-04 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 26,250 55,039 91.18
2023-03-16 2023-03-14 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -1,768 28,789 -5.79 18.73 -33,118 539,276
2022-12-20 2022-12-16 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -1,938 30,557 -5.96 19.36 -37,519 591,568
2022-12-20 2022-12-16 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -3,492 32,495 -9.70 18.77 -65,561 610,081
2022-11-28 2022-11-23 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -277 35,987 -0.76 21.99 -6,092 791,405
2022-11-28 2022-11-23 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -600 36,264 -1.63 21.38 -12,826 775,197
2022-05-26 2022-05-24 4 IGMS IGM Biosciences, Inc.
Common Stock
S - Sale -938 36,864 -2.48 17.10 -16,043 630,518
2022-05-17 2022-05-13 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 825 37,802 2.23 12.38 10,214 467,989
2022-03-17 2022-03-15 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 14,477 36,977 64.34
2022-03-15 2022-03-12 4 IGMS IGM Biosciences, Inc.
Stock Option (right to buy)
A - Award 75,000 75,000
2022-03-15 2022-03-12 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 12,500 22,500 125.00
2021-11-19 2021-11-15 4 IGMS IGM Biosciences, Inc.
Common Stock
A - Award 10,000 10,000
2021-08-03 2021-07-30 4 IGMS IGM Biosciences, Inc.
Stock Option (right to buy)
A - Award 150,000 150,000
2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
D - Sale to Issuer -113,153 0 -100.00
2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
D - Sale to Issuer -44,710 0 -100.00
2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
D - Sale to Issuer -70,398 0 -100.00
2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
D - Sale to Issuer -4,570 0 -100.00
2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
D - Sale to Issuer -58,114 0 -100.00
2020-04-07 2020-04-07 4 FTSV Forty Seven, Inc.
Common Stock
D - Sale to Issuer -3,906 0 -100.00
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -2,797 113,153 -2.41
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -11,418 44,710 -20.34
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -7,020 70,398 -9.07
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -8,333 4,570 -64.58
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -49,627 58,114 -46.06
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale -79,195 3,906 -95.30 95.42 -7,556,787 372,711
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 2,797 83,101 3.48 35.75 99,993 2,970,861
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 11,418 80,304 16.58 8.76 99,993 703,262
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 7,020 68,886 11.35 5.27 36,995 363,029
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 8,333 61,866 15.57 4.88 40,686 302,061
2020-04-03 2020-04-01 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 49,627 53,533 1,270.53 2.02 99,998 107,869
2019-12-17 2019-12-13 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
A - Award 115,950 115,950
2019-12-11 2019-12-10 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -10,000 0 -100.00 35.00 -350,000
2019-12-11 2019-12-10 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 10,000 10,000 2.02 20,150 20,150
2019-12-11 2019-12-09 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -10,000 107,741 -8.49
2019-12-10 2019-12-09 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -10,000 117,741 -7.83
2019-12-10 2019-12-09 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -10,000 0 -100.00 30.00 -300,000
2019-12-10 2019-12-09 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 10,000 10,000 2.02 20,150 20,150
2019-08-21 2019-08-16 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -663 0 -100.00 6.36 -4,216
2019-05-07 2019-05-03 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -8,000 127,741 -5.89
2019-05-07 2019-05-03 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -8,000 0 -100.00 17.99 -143,951
2019-05-07 2019-05-03 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 8,000 8,000 2.02 16,120 16,120
2019-04-08 2019-04-04 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -8,000 0 -100.00 16.39 -131,105
2019-04-08 2019-04-04 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 8,000 8,000 2.02 16,120 16,120
2019-04-08 2019-03-04 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -8,000 135,741 -5.57
2019-03-06 2019-03-04 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -8,000 143,741 -5.27
2019-03-06 2019-03-04 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -8,000 0 -100.00 16.94 -135,550
2019-03-06 2019-03-04 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 8,000 8,000 2.02 16,120 16,120
2019-02-21 2019-02-19 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -2,500 0 -100.00 15.05 -37,621
2019-02-05 2019-02-04 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -8,000 151,741 -5.01
2019-02-05 2019-02-04 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -8,000 0 -100.00 14.86 -118,874
2019-02-05 2019-02-04 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 8,000 8,000 2.02 16,120 16,120
2019-01-08 2019-01-04 4 FTSV Forty Seven, Inc.
Stock Option (right to buy)
M - Exercise -8,000 159,741 -4.77
2019-01-08 2019-01-04 4 FTSV Forty Seven, Inc.
Common Stock
S - Sale X -8,000 0 -100.00 15.55 -124,362
2019-01-08 2019-01-04 4 FTSV Forty Seven, Inc.
Common Stock
M - Exercise 8,000 8,000 2.02 16,120 16,120
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)